chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Small lump under the chin, maybe a quarter size; This spontaneous case was reported by a consumer and describes the occurrence of MASS (Small lump under the chin, maybe a quarter size) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergy to aspirin (GP6 whatever)) and Food allergy (Allergy to tomatoes).    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced MASS (Small lump under the chin, maybe a quarter size). At the time of the report, MASS (Small lump under the chin, maybe a quarter size) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  The patient said small lump under the chin is like a ball, not painful, and not affecting the breathing or anything.  Treatment information was not provided.
Red blotches on skin on different parts of the body: chest, upper breasts, breasts near underarms, stomach, inside of elbows
He had developed bronchitis during the week of 10/12/2009. He was being treated by his physician with albuterol nebulizer treatment as needed. According to his mother, he was asymptomatic and afebrile on the date that he received the H1N1 vaccine. She reports that on the date that he received the vaccine (10/26/2009 0800), he arrived home from school and was 'worn out' with an unusual level of fatigue. She stated that he felt hot to the touch and that he had a fever of 101.7. She states that he also had developed a dry cough. He denied Nausea, vomiting or diarrhea. He had no shortness of breath, no chest pain, no nasal congestion. Mother states that he had a normal appetite on that evening and on the subsequent days of illness. Mother states that he remained home from school on Tuesday 10/27/2009 and was afebrile most of the day. On Tuesday night, his fever returned so he remained home from school on Wednesday 10/28/2009, as well. He was afebrile Wednesday and remained symptom free. He returned to school on Thursday 10/29/2009. Mother contacted her son's doctor by phone, no office visit was needed dertemined the physician. As of (11/13), mother states that he is coughing but she attributes it to sinus drainage caused by recent fluctuations in the outside temperature and his seasonal allergies.
Upset stomach, sore arm, hot arm, itchy arm, serve body aches, and spike in blood pressure.
Patient fainted approximately 30 seconds after vaccine administration and feel from the exam table to the floor. Patient was unresponsive for approximately 10-15 seconds before opening eyes. Patient was alert and oriented times four. Patient had an approximated 2" x 1.5" lump palpated on the crown of her head and an approximated one half inch abrasion to the left elbow.  9:16 AM- vitals stable: B/P 132/82, pulse 80, oxygen saturation 99%; EMS called. 09:24 AM - Fire and EMS arrived. EMS performed evaluation on patient and deemed her medically clear to return home under parental supervision. Father of patient declined ambulance transport to hospital. Patient and father encouraged to follow-up at their local urgent care for possible imaging or any worsening or lack of improvement of symptoms. Nursing, staff, and parent, present for the entire episode.  09:45 AM - Patient ambulated without assistance with parent to car and left the parking lot of the Health department without further events occuring.
This spontaneous report was received from a medical assistant referring to 1 year old male patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 11-JAN-2018, the patient was vaccinated with VARIVAX (lot # N019128, expiration date 22-JUN-2019) (dose and route of administration were not reported) for prophylaxis. There was no adverse effect reported. It was confirmed that sterile diluent (lot # M046371, expiration date 05-JUL-2019) used for reconstitution was properly stored. No adverse effects reported. Administered dose of vaccine experienced the temperature excursion of 6 degrees Fahrenheit to 14 degrees Fahrenheit for 56 hours 11 minutes. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1801USA007476: US-009507513-1801USA006791.
Woke at 4 am with a the right side of my tongue swollen; This is a spontaneous report from a contactable 50-year-old non-pregnant female consumer reported for herself that she received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EN5318, Expiration date: unknown) via an unspecified route of administration on Left arm on 02Feb2021 at 20.45 at single dose for COVID-19 Immunization. The patient medical history included thyroid disease and Allergies to Augmentin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since vaccination, patient had not tested for COVID-19. Concomitant medication included Levothyroxine sodium (88mcg). On 03Feb2021 04:00 am, the patient waited for 15 minutes required and did not feel anything, patient went home, went to bed. Woke at 4 am with a the right side of my tongue swollen. The patient did not receive any treatment. The outcome for event was recovering.
Child developed rash (red, flat, no pimples) all over body on 6/30/08.  Temp 100 degrees F. Rash was shown mostly of face, abdomen, less on arms, legs.  Reported rash 7/1/08.  Called parent back 7/2: rash pink, receding, no fever; eating & drinking OK.
I incorrectly reconstituted the vial with 0.8ml instead of 1.8ml.  Error was noticed before I drew out the full 6 syringes. The first syringe was placed with 1 other syringe that was correctly drawn from the previous bottle. Pt received one of these syringes. Unknown if they received the regular strength of .3 or double strength syringe. Pt has been notified and counseled. This was his second dose.
Beginning about 10 days after vaccination, the patient noticed pain in his arm and he started ?not feeling so great.? Over several days, this pain began to radiate and involve muscle and bone aches. He continued to feel ill to what he described as the worst symptoms on Monday, April 26th, which included severe pain, high blood pressure (211/113 documented by the ER), symptoms similar to cardiac event. The patient was seen by Emergency Department who did not find a diagnosis, but gave the patient medication to lower blood pressure and referred further treatment to his Primary Care Provider.  Blood pressure mediation was taken to lower his blood pressure and clonidine 0.1mg was prescribed by his PCP because of elevated BP (over 150/90). The patient was also instructed to take Advil for pain and was referred to get an X-ray  with follow up in 2 weeks on 5/13.
I had a sinus infection about two weeks later, but as I have seasonal allergies, I'm sure that was not related. I also developed an eczema flare-up around 4/17/21 on my hands, stomach, arms, face, and neck that has not gone away. I have begun treatment with a dermatologist for the flare-up and am currently being tested for psoriasis. I did not have any eczema or psoriasis symptoms before. My dermatologist mentioned that they have seen previously dormant auto-immune disorders becoming active after the vaccine, and this was likely the case with me.
Pt given KINRIX (DTAP/IPV) at 2 mo of age. Pt's mother reports no adverse events.
This case was reported by a nurse via sales rep and described the occurrence of pain in arm in a female patient who received Men B NVS (Bexsero) for prophylaxis. Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis. On 10th December 2021, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On 10th December 2021, immediately after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced pain in arm and vaccine administered at inappropriate site. On an unknown date, the outcome of the pain in arm was not recovered/ not resolved and the outcome of the vaccine administered at inappropriate site was unknown. It was unknown if the reporter considered the pain in arm to be related to Bexsero and Bexsero Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided are as follows: The age at vaccination was not reported. The patient received a dose of Bexsero in her arm and had immediate pain in that arm. The reporter suspected that injection was given too high up the arm, which led to vaccine administered at inappropriate site. The pain was continued. Limited details were available. The reporter consented to follow-up.
3MAR devel on rt arm area of inject bright red itchy & hot to touch, sl tender to touch, not hard; 8MAR no change in signs;
Developed hives all over the body after receiving the Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Developed hives all over the body after receiving the Moderna vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (Developed hives all over the body after receiving the Moderna vaccine). At the time of the report, URTICARIA (Developed hives all over the body after receiving the Moderna vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment medication were not provided.
Temp to 103 degrees on 07/24/02, 07/25/2002 developed HA, SA and itchy vesicular rash that quickly spread from shoulders, trunk, scalp and extremities. Diagnosis: Varicella post vaccine.
Pt recv vax on 1/6/99; on 1/7/99 pt exp fever (101.2) & swollen Rt arm
Chest pain and stabbing pains left side of chest ongoing for 24 hrs after first shot and ongoing after second shot and current 11/04/21
Patient was given a 0.5ml dose of the Moderna Bivalent dose 6 days after expiration
Patient was upset /very upset about the uncertainty of her condition; Rash like a big spot; Swelling on lymph nodes; Arm pit became tender; Mental state was distressed; Skin was peeling off; Sensation of a scar; Arm pit became red; Arm pit became hot and irritated; COVID19 vaccine activated the cancer cells; This spontaneous case was reported by a consumer and describes the occurrence of EMOTIONAL DISTRESS (Mental state was distressed), SKIN EXFOLIATION (Skin was peeling off), SCAR PAIN (Sensation of a scar), ERYTHEMA (Arm pit became red) and FEELING HOT (Arm pit became hot and irritated) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033C21A and 02XC21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Mastectomy bilateral in 2013 and Lymph node dissection (2 lymph nodes which were benign.). Concurrent medical conditions included Breast cancer NOS recurrent (affected on 1% of patients who had a bilateral mastectomy) since March 2015.   On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Aug-2021, the patient experienced EMOTIONAL DISTRESS (Mental state was distressed), SKIN EXFOLIATION (Skin was peeling off), SCAR PAIN (Sensation of a scar), ERYTHEMA (Arm pit became red), FEELING HOT (Arm pit became hot and irritated), VACCINATION COMPLICATION (COVID19 vaccine activated the cancer cells), RASH (Rash like a big spot), LYMPHADENOPATHY (Swelling on lymph nodes) and AXILLARY PAIN (Arm pit became tender). On an unknown date, the patient experienced DEPRESSED MOOD (Patient was upset /very upset about the uncertainty of her condition). At the time of the report, EMOTIONAL DISTRESS (Mental state was distressed), SKIN EXFOLIATION (Skin was peeling off), SCAR PAIN (Sensation of a scar), ERYTHEMA (Arm pit became red), FEELING HOT (Arm pit became hot and irritated), VACCINATION COMPLICATION (COVID19 vaccine activated the cancer cells), RASH (Rash like a big spot), LYMPHADENOPATHY (Swelling on lymph nodes) and AXILLARY PAIN (Arm pit became tender) had not resolved and DEPRESSED MOOD (Patient was upset /very upset about the uncertainty of her condition) outcome was unknown.            Patient stated took concomitant medications of breast cancer medication and since 2016 and took ultrasound test.  Patient suggested the COVID19 vaccine activated the cancer cells, that she was on remission and that she wasn't sure that the vaccine was safe for cancer patients and that she didn't want her lymph nodes to be bothered.  No treatment medications were provided by reporter.
none, 18 month old was given o.5cc of fluzone in right leg. CDC notified and was told no serious adverse reaction. Child may have increased local reaction at injection site. Also instructed that child recieve 0.25cc in 4 weeks from initial injection.
Information has been received from a physician concerning a 26 year old female with a poor immune system and a history of helicobacter pylori, who on 25-APR-2007 was vaccinated with the first dose of Gardasil vaccine. Within a few days, in approximately April 2007, the patient experienced shoulder and neck pain on both her right and left sides which lasted for an extended period of time. "Many" lab tests (unspecified) were conducted, results not reported. The patient had a second dose of Gardasil vaccine on 28-JUN-2007. After the second dose, in approximately June 2007, the patient experienced the same shoulder and neck pain but this time the pain also extended down to her rib cage on both her right and left sides. The patient went to the physician's office on 31-OCT-2007 and the physician decided to discontinue therapy and not give the patient the third dose of Gardasil vaccine. Additional information has been requested.
Received dose from vials beyond 30-day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received dose from vials beyond 30-day use by date) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received dose from vials beyond 30-day use by date). On 14-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Received dose from vials beyond 30-day use by date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Date of refrigeration  was on 7-may-2021. Concomitant medication use was unknown Treatment information was unknown
Itching on her left arm only; Rash on her left arm only; My arm was red at the injection site; My arm was hot at the injection site; my arm was hard-like at the injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE ERYTHEMA (My arm was red at the injection site), VACCINATION SITE WARMTH (My arm was hot at the injection site), VACCINATION SITE INDURATION (my arm was hard-like at the injection site), VACCINATION SITE PRURITUS (Itching on her left arm only) and VACCINATION SITE RASH (Rash on her left arm only) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 040A21A) for COVID-19 vaccination.     The patient's past medical history included Hysterectomy. Concurrent medical conditions included Sensitive skin. Concomitant products included OXYCODONE for Neck pain, METFORMIN, LISINOPRIL, ESTROGENS CONJUGATED (PREMARIN) and DULOXETINE HYDROCHLORIDE (CYMBALTA) for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (My arm was red at the injection site), VACCINATION SITE WARMTH (My arm was hot at the injection site) and VACCINATION SITE INDURATION (my arm was hard-like at the injection site). On 10-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itching on her left arm only) and VACCINATION SITE RASH (Rash on her left arm only). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) in March 2021 for Allergy, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE ERYTHEMA (My arm was red at the injection site), VACCINATION SITE WARMTH (My arm was hot at the injection site), VACCINATION SITE INDURATION (my arm was hard-like at the injection site), VACCINATION SITE PRURITUS (Itching on her left arm only) and VACCINATION SITE RASH (Rash on her left arm only) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-101509 (Patient Link).
Pt had hepatitis A and Meningococcal group B vaccine on 12/28/18, in both right and left deltoid. It is unknown which vaccine was injected in which arm. Pt has red, swollen rash on right deltoid.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information has been received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date in 2006, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. On an unknown date later in 2010, the patient was treated for a blistering vesicular outbreak, which was diagnosed as herpes zoster. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
itching 10 minutes after administration of vaccine no tongue or lip swelling benadryl 50 mg X1
I had pain the same day and resolved 1 week later and then started to developed symptoms of COVID 19. Also had a runny nose and headache. After Covid course ended after 2.5 weeks then devolved GI symptoms Covid Colitis and a new headache pattern and sensitivity to touch. Nummular headache and tinnitus and hearing loss.
Inguinal and cervical lymphadenopathy and nodular reaction at injection site located at thigh.
On 29 Friday, at appx 0100, several hours after receiving influenza, Tdap, MCV4P and IPV vaccines, pt presented to the Emergency Center for symptoms of angioedema of the cheeks, lips, associated with hives on her arms and chest. Denies associated lightheadedness, syncope, shortness of breath, wheezing, cough, conjunctivitis, rhinitis, vomiting, abdominal pain or diarrhea. She received IV BENADRYL, and symptoms resolved in 3-4 hours. She then followed with the trainee health clinic on 1 April and was given ZYRTEC, prednisone, and ZANTAC. However she only took one of these, she is unsure which, on one occasion d/t itching. Her symptoms have not since recurred.
At 3:00 pm 3/11/21 patient's son phoned with patient present stating patient had chest pain and felt heaviness in chest, this nurse recommended and encouraged patient's son to phone 911 and patient to go to ER. This nurse followed up with patient 3/12/21 1:50 pm  and patient was taken to ER 3/11/21 and given nitro, patient then declined diagnostic testing. Pt kept for overnight observation and sent home 3/12/21 10 am.
Frequent loose stool and diaper rash. Managed conservatively with probiotics, bland diet, and barriers creams. 5 days of symptoms at time of visit.
Headache, Fever, NauseaVomiting, Fatigue, Chills
After getting the vaccine I started having chills, I wasn't able to hold things steady. The next day I was sweating and having chills. I called 911 to see what I should do because I was still shaking. I was supposed to give myself an injection for hydrocortisone, but the shaking was so bad I wasn't able to. My blood pressure also dropped it was hard to keep it above 80.
Baseball sized, red, raised area at site of injection with several red, warm to touch areas down arm.  Achy with fever for 3-4 days, tremors, high level of discomfort in arm.
After my daughter received two shots I was called back in by the doctor's office claiming there was a measles outbreak and wanted all children to come back in for their first measles shot. I told them my child is too young for the shot they said in cases like this we can "bend" the rules. After she received this shot, her pupils were dilated for at least 48 hours. She also was very lethargic. Within the first 24 hours her neck would convulse her head back, so fast, it looked like a tic or seizure. Her injected leg also was very stiff and would not bend. Myself and her great grandmother would bicycle her legs to try to get the muscles from being so rigid. Her body became inflamed with Eczema. I called the doctor's office and told them her head is jerking back and they told me to write it down in a journal and proceeded to tell me there was no measles outbreak. So needless to say we never went back there.  My daughter also regressed in her already developed motor skills. She would pass a toy slowly between her hands as if it was the first time she did. She has since been referred to an Occupational Therapist for her outbursts and meltdowns, obsessive compulsiveness, lack of speech. Her OT said she has all the telltale signs of Autism but cannot give an official diagnosis. After she received the MMR vaccine WAY too early I watched her change physically, mentally, and emotionally into something else.